BAFF signaling in health and disease.
File(s)1-s2.0-S0952791521000832-main.pdf (1.11 MB)
Published version
Author(s)
Schweighoffer, Edina
Tybulewicz, Victor Lj
Type
Journal Article
Abstract
BAFF is a critical cytokine supporting the survival of mature naïve B cells, acting through the BAFFR receptor. Recent studies show that BAFF and BAFFR are also required for the survival of memory B cells, autoimmune B cells as well as malignant chronic lymphocytic leukaemia (CLL) cells. BAFFR cooperates with other receptors, notably the B cell antigen receptor (BCR), a process which is critical for the expansion of autoimmune and CLL cells. This crosstalk may be mediated by TRAF3 which interacts with BAFFR and with CD79A, a signalling subunit of the BCR and the downstream SYK kinase, inhibiting its activity. BAFF binding to BAFFR leads to degradation of TRAF3 which may relieve inhibition of SYK activity transducing signals to pathways required for B cell survival. BAFFR activates both canonical and non-canonical NF-κB signalling and both pathways play important roles in the survival of B cells and CLL cells.
Date Issued
2021-08-02
Date Acceptance
2021-06-18
Citation
Current Opinion in Immunology, 2021, 71, pp.124-131
ISSN
0952-7915
Publisher
Elsevier
Start Page
124
End Page
131
Journal / Book Title
Current Opinion in Immunology
Volume
71
Copyright Statement
© 2021 The Authors. Published by Elsevier Ltd. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
License URL
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/34352467
PII: S0952-7915(21)00083-2
Subjects
Immunology
1107 Immunology
Publication Status
Published
Coverage Spatial
England
Date Publish Online
2021-08-02